Although most sporadic and hereditary BRCA1 cancers carry the TNBC phenotype (ER−, PR−, HER2−), the majority of hereditary BRCA2 cancers are of a luminal type (HR+, HER2-) [62,63]. Here, HR is linked to cancer.